Swog Cancer Research Network

This study is for people with advanced or recurrent non-small cell lung cancer that has a specific genetic change (EGFR mutation). It compares two treatment approaches: taking a pill called afatinib alone, or taking afatinib plus receiving an IV drug called cetuximab. The main go…

This study is testing if adding a new drug, asciminib, to a standard treatment regimen works better for adults newly diagnosed with a specific, aggressive form of leukemia called Philadelphia chromosome-positive ALL. The goal is to see if this combination can drive the cancer int…

This study is for people with multiple myeloma who have had a stem cell transplant. It tests whether adding a drug called daratumumab to the standard maintenance drug lenalidomide is better at keeping the cancer from coming back. A key part of the study uses a very sensitive bloo…

This study is testing an oral drug called selpercatinib for people with advanced non-small cell lung cancer that has a specific genetic change called a RET fusion. The goal is to see how well the drug shrinks tumors and controls the cancer by blocking the abnormal protein driving…

This large study tested whether adding a drug called everolimus to standard hormone therapy is better at preventing breast cancer from coming back. It involved nearly 2,000 patients with a high-risk type of breast cancer that is fueled by hormones. The goal was to see if the one-…

This study is testing an experimental pill called AMG 510 for people with advanced non-small cell lung cancer that has a specific genetic change called KRAS G12C. The pill is designed to block this specific mutation, which can drive cancer growth, in patients whose cancer has wor…

This study is testing if adding a drug called ruxolitinib to standard CML medications helps patients achieve a deeper level of remission. It involves adults with chronic phase CML who still have a small amount of detectable disease despite being on treatment. Participants are ran…

This study tests whether web-based decision support tools help women at high risk for breast cancer make more informed choices about preventive medications. It involves 412 women with specific high-risk breast conditions who are considering drugs that can lower their cancer risk.…

This study tests whether a financial counseling program can reduce money problems and stress for people with cancer and their partners. It compares two groups: one gets basic financial education, and the other gets that plus monthly meetings with a financial counselor. The goal i…

This study aims to create a tool to predict which cancer patients are most likely to develop nerve damage (like tingling or numbness in hands and feet) from a common class of chemotherapy drugs called taxanes. Researchers will follow over 1,300 patients with breast, lung, or ovar…

This study is testing whether having a team of cancer genetics experts review a patient's tumor test results helps doctors choose more effective treatments. It compares the usual approach where doctors review results alone against having a special 'genomic tumor board' provide ex…

This study is testing whether a specific substance in the blood (called miRNA 371) can help doctors predict if testicular cancer will return after initial treatment. Researchers are following 956 newly diagnosed patients for up to 3 years, collecting blood samples every few month…